Phospho-PXN (Ser272) Antibody

What is Phospho-PXN (Ser272) Antibody and what does it detect?

Phospho-PXN (Ser272) Antibody is a phosphorylation-specific antibody that selectively recognizes the paxillin protein only when it is phosphorylated at serine residue 272. This antibody detects endogenous levels of phosphorylated paxillin at this specific site, making it valuable for studying post-translational modifications in paxillin-mediated signaling pathways. The antibody specifically recognizes the phosphorylated motif M-A-S(p)-L-S in the human paxillin sequence . This high specificity enables researchers to investigate the activation state of paxillin in various experimental conditions without detecting the non-phosphorylated form of the protein.

What species reactivity does the Phospho-PXN (Ser272) Antibody exhibit?

The Phospho-PXN (Ser272) Antibody has demonstrated reactivity with human samples . When planning experiments with different species, researchers should verify cross-reactivity by comparing the sequence homology of the phosphorylation site and surrounding amino acids across species. If the antibody is intended for use with non-human samples, preliminary validation experiments are strongly recommended to confirm specificity and sensitivity in the species of interest.

What are the recommended storage conditions for maintaining antibody performance?

For optimal performance and longevity, Phospho-PXN (Ser272) Antibody should be stored at -20°C for up to one year from the date of receipt . The antibody is typically supplied in a stabilizing buffer containing phosphate buffered saline (without Mg²⁺ and Ca²⁺), pH 7.4, 150mM NaCl, 0.02% sodium azide, and 50% glycerol . Researchers should avoid repeated freeze-thaw cycles, which can compromise antibody functionality. If frequent use is anticipated, aliquoting the antibody into smaller volumes prior to freezing is recommended to minimize freeze-thaw cycles and maintain antibody integrity.

How does phosphorylation at Ser272 affect paxillin function in focal adhesion dynamics?

Phosphorylation of paxillin at Ser272 represents a critical regulatory mechanism in focal adhesion turnover and cell migration. This post-translational modification typically occurs downstream of growth factor signaling and integrates with other phosphorylation events on paxillin to orchestrate complex cytoskeletal rearrangements. When using Phospho-PXN (Ser272) Antibody, researchers can monitor this specific phosphorylation event to elucidate how various stimuli or inhibitors influence focal adhesion dynamics. Quantitative analysis of phospho-Ser272 levels using this antibody can reveal temporal patterns of activation during cell migration, adhesion formation, and disassembly processes that would not be detectable with antibodies targeting total paxillin protein.

What is the relationship between Ser272 phosphorylation and other phosphorylation sites on paxillin?

Paxillin contains multiple phosphorylation sites that function in concert to regulate its scaffolding activities. Ser272 phosphorylation often exhibits interdependence with other key sites, including tyrosine phosphorylation at Y31 and Y118. Research using phospho-specific antibodies like Phospho-PXN (Ser272) alongside antibodies targeting other phosphorylation sites enables mapping of the hierarchical or sequential phosphorylation patterns on paxillin. Researchers should consider designing experiments that simultaneously monitor multiple phosphorylation sites to obtain a comprehensive understanding of paxillin regulation. Phosphatase treatment controls can help distinguish between independent versus cooperative phosphorylation events when interpreting results from multiplexed phospho-antibody analyses.

What are the optimal cell lysis conditions to preserve paxillin Ser272 phosphorylation?

Preserving phosphorylation status during sample preparation is critical for accurate detection with Phospho-PXN (Ser272) Antibody. Optimal lysis conditions include buffers containing both phosphatase inhibitor cocktails (e.g., sodium orthovanadate, sodium fluoride, β-glycerophosphate) and protease inhibitors. RIPA or modified RIPA buffers supplemented with 1-2% NP-40 or Triton X-100 effectively solubilize paxillin from focal adhesions while maintaining phosphorylation integrity. Researchers should perform lysis at 4°C and process samples rapidly to minimize dephosphorylation by endogenous phosphatases. When comparing experimental conditions, standardization of the lysis protocol is essential to ensure that observed differences in phosphorylation levels are biologically significant rather than artifacts of sample preparation.

How should positive and negative controls be designed for Phospho-PXN (Ser272) Antibody validation?

Rigorous validation of Phospho-PXN (Ser272) Antibody requires thoughtfully designed controls. For positive controls, treat cells with agents known to induce paxillin Ser272 phosphorylation, such as serum, growth factors (EGF, PDGF), or phorbol esters. Negative controls should include lambda phosphatase treatment of cell lysates to remove phosphate groups, which should eliminate antibody recognition if the antibody is truly phospho-specific. Additionally, siRNA knockdown of paxillin should result in loss of signal, confirming specificity. A peptide competition assay using the phosphorylated immunogen peptide versus the non-phosphorylated equivalent can definitively demonstrate phospho-specificity. Document these validation experiments thoroughly, as they establish the foundation for interpreting all subsequent experimental results with this antibody.

What is the recommended sample preparation protocol for detecting phosphorylated paxillin in Western blot applications?

For optimal detection of phosphorylated paxillin in Western blot applications, collect cells by scraping rather than enzymatic methods, as trypsinization can alter phosphorylation status. Lyse cells in ice-cold buffer containing 50mM Tris-HCl pH 7.5, 150mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, with freshly added phosphatase inhibitors (10mM NaF, 1mM Na₃VO₄, 10mM β-glycerophosphate) and protease inhibitor cocktail. Sonicate briefly to shear DNA and clarify lysates by centrifugation at 14,000×g for 15 minutes at 4°C. Determine protein concentration using a detergent-compatible assay and load equal amounts (20-40μg) per lane. Use freshly prepared SDS-PAGE gels (8-10%) for optimal resolution of the 68kDa paxillin protein. Transfer to PVDF membranes and block with 5% BSA (not milk, which contains phosphatases) in TBST before incubating with Phospho-PXN (Ser272) Antibody at 1:1000 dilution overnight at 4°C.

How can quantitative analysis of paxillin phosphorylation be performed reliably?

Quantitative analysis of paxillin phosphorylation requires normalization strategies to account for technical and biological variability. When analyzing Western blot data, first normalize phospho-Ser272 signal to total paxillin levels (using a separate total paxillin antibody on stripped membranes or parallel blots) to distinguish changes in phosphorylation from changes in protein expression. Further normalize to loading controls such as GAPDH or β-actin. For immunofluorescence quantification, measure the integrated density of phospho-Ser272 signal specifically at focal adhesions (identified by co-staining with vinculin or other focal adhesion markers) rather than total cellular signal. Present data as phospho-to-total ratios rather than absolute intensities, and perform statistical analysis across multiple biological replicates to ensure reproducibility and significance of observed changes in phosphorylation.

What immunoprecipitation protocol is recommended when using Phospho-PXN (Ser272) Antibody?

For immunoprecipitation of phosphorylated paxillin with Phospho-PXN (Ser272) Antibody, prepare cell lysates in a gentle lysis buffer (25mM Tris-HCl pH 7.4, 150mM NaCl, 1% NP-40, 5% glycerol, 1mM EDTA) supplemented with phosphatase and protease inhibitors. Pre-clear 500μg of protein lysate with 20μl of Protein A/G beads for 1 hour at 4°C to reduce non-specific binding. Incubate pre-cleared lysates with 2-5μg of Phospho-PXN (Ser272) Antibody overnight at 4°C with gentle rotation. Add 30μl of fresh Protein A/G beads and incubate for an additional 2-3 hours. Wash immunoprecipitates four times with lysis buffer, with the final wash in TBS to remove detergents. Elute bound proteins by boiling in Laemmli sample buffer and analyze by Western blotting. For validation, probe the immunoprecipitated material with a different paxillin antibody that recognizes a distinct epitope to confirm identity.

How can the Phospho-PXN (Ser272) Antibody be applied in immunofluorescence studies?

Although the Phospho-PXN (Ser272) Antibody is primarily validated for Western blot applications , adapting it for immunofluorescence requires careful optimization. Fix cells in 4% paraformaldehyde for 15 minutes at room temperature, followed by permeabilization with 0.2% Triton X-100 for 5 minutes. Block with 5% normal goat serum and 1% BSA in PBS for 1 hour at room temperature. Incubate with Phospho-PXN (Ser272) Antibody at 1:100-1:500 dilution (requiring empirical determination of optimal concentration) overnight at 4°C. After washing, apply fluorophore-conjugated secondary antibodies for 1 hour at room temperature. Include co-staining with total paxillin or other focal adhesion markers to confirm localization patterns. Phosphatase-treated samples and paxillin-depleted cells serve as essential negative controls to validate staining specificity. Z-stack imaging with confocal microscopy enables precise localization of phosphorylated paxillin within three-dimensional focal adhesion structures.

What visualization techniques can enhance the detection of phosphorylated paxillin in complex samples?

Advanced visualization techniques can significantly improve detection sensitivity and specificity of phosphorylated paxillin in complex biological samples. For low-abundance phosphorylation events, consider using tyramide signal amplification (TSA) with the Phospho-PXN (Ser272) Antibody to enhance fluorescence signal while maintaining spatial resolution. Proximity ligation assay (PLA) can detect interactions between phosphorylated paxillin and other focal adhesion proteins with single-molecule sensitivity, providing quantifiable interaction data in situ. For tissue sections, implement antigen retrieval methods optimized for phospho-epitopes (citrate buffer pH 6.0 with microwave heating) before antibody incubation. In multicolor immunofluorescence, use spectral unmixing algorithms to separate overlapping fluorophore emissions and reduce autofluorescence background. For quantitative analysis, employ machine learning algorithms to automatically identify and measure phospho-paxillin-positive focal adhesions across multiple images for unbiased assessment.

How should researchers address weak or absent signals when using Phospho-PXN (Ser272) Antibody?

When encountering weak or absent signals with Phospho-PXN (Ser272) Antibody, systematically evaluate several variables. First, confirm the phosphorylation status of your samples by treating control cells with phosphatase inhibitors (calyculin A or okadaic acid) to enhance phosphorylation signals. Verify protein loading with total paxillin antibodies to ensure sufficient target protein is present. Examine antibody concentration and incubation conditions—consider increasing antibody concentration to 1:500 or extending incubation time to overnight at 4°C. Enhance signal detection using high-sensitivity ECL substrates or signal amplification systems. Assess blocking solutions, as milk-based blockers can contain phosphatases that degrade the epitope; substitute with 5% BSA in TBST. Finally, verify that transfer conditions are optimized for high molecular weight proteins, using lower methanol concentrations and extended transfer times if necessary.

How can researchers distinguish between specific and non-specific bands when interpreting Western blot results?

Distinguishing specific from non-specific bands requires systematic validation approaches. The Phospho-PXN (Ser272) Antibody should detect a primary band at approximately 68kDa corresponding to phosphorylated paxillin . To confirm band specificity, perform parallel blots with: (1) phosphatase-treated lysates to eliminate phospho-specific signals; (2) paxillin-depleted samples via siRNA knockdown; and (3) peptide competition assays using the phosphorylated immunogenic peptide. Non-specific bands should remain unchanged in phosphatase-treated samples but disappear in competition assays. Additionally, stimulate cells with growth factors known to increase paxillin phosphorylation—specific bands should show intensity changes corresponding to biological regulation. Document molecular weight standards on all blots and maintain consistent sample preparation protocols to enable reliable comparison across experiments. When multiple bands appear, consider the possibility of splice variants or proteolytic fragments, which can be verified through mass spectrometry analysis.

What factors might contribute to variability in paxillin phosphorylation detection across experiments?

Experimental variability in paxillin phosphorylation detection can stem from multiple sources that require systematic control. Cell culture conditions significantly impact baseline phosphorylation—standardize serum concentrations, cell density, and time since last media change. Cell harvesting methods affect phosphorylation status; direct lysis in plates with phosphatase inhibitors preserves modifications better than enzymatic detachment. For adherent cells, phosphorylation states change rapidly upon detachment, so standardize the time between detachment and lysis. Antibody lot-to-lot variability can introduce inconsistencies; maintain reference samples to calibrate new antibody lots. Sample storage conditions influence phospho-epitope stability—avoid multiple freeze-thaw cycles and store lysates at -80°C with phosphatase inhibitors. Document experimental timing precisely, as circadian rhythms can affect cellular signaling. Finally, establish quantitative standard curves with known amounts of phosphorylated recombinant protein to enable absolute quantification and improve inter-experimental comparability.

How does the specificity of Phospho-PXN (Ser272) Antibody compare with antibodies targeting other paxillin phosphorylation sites?

The Phospho-PXN (Ser272) Antibody displays high specificity through its ability to detect paxillin only when phosphorylated at the Ser272 position . This specificity is achieved through affinity purification techniques that remove non-phospho-specific antibodies . When comparing with antibodies targeting other phosphorylation sites (such as Tyr31, Tyr118, or Ser178), researchers should understand that each site has distinct biological significance and kinetics of phosphorylation. While tyrosine phosphorylation sites often respond rapidly to integrin engagement and growth factor stimulation, serine phosphorylation including Ser272 may exhibit different temporal dynamics and regulatory mechanisms. For comprehensive signaling studies, researchers should employ multiple phospho-specific antibodies in parallel, with appropriate positive controls for each site. Cross-reactivity testing using phosphomimetic mutants (S272D or S272E) versus phospho-null mutants (S272A) can provide definitive evidence of antibody specificity compared to antibodies targeting nearby phosphorylation sites.

What are the key experimental differences between studying paxillin phosphorylation in 2D versus 3D cell culture systems?

Detecting paxillin phosphorylation at Ser272 presents distinct challenges in 2D versus 3D culture systems, requiring adaptations in both experimental approach and data interpretation. In 2D cultures, paxillin localizes predominantly to distinct focal adhesions at the cell-substrate interface, facilitating straightforward imaging and biochemical analysis. In contrast, 3D matrices disperse focal adhesions throughout multiple planes, necessitating advanced imaging techniques such as deconvolution microscopy or light sheet imaging for adequate visualization. For biochemical analysis, 3D culture systems require specialized extraction protocols to efficiently solubilize matrix-embedded cells without disrupting phosphorylation status. The phosphorylation pattern itself may differ significantly between 2D and 3D environments, with Ser272 potentially playing distinct roles in each context. Researchers should develop parallel validation protocols for both systems, including appropriate matrix controls, and avoid direct quantitative comparisons between 2D and 3D data without accounting for fundamental differences in cellular architecture and matrix interactions.

How might mass spectrometry complement antibody-based detection of paxillin phosphorylation at Ser272?

Mass spectrometry (MS) offers complementary advantages to antibody-based detection of paxillin phosphorylation, particularly for comprehensive phosphorylation site analysis. While the Phospho-PXN (Ser272) Antibody provides site-specific detection , MS can simultaneously identify multiple phosphorylation sites and their stoichiometry, revealing potential crosstalk between Ser272 and other phosphorylation events. For MS analysis, immunoprecipitate paxillin from cell lysates using total paxillin antibodies, followed by tryptic digestion and phosphopeptide enrichment using titanium dioxide (TiO₂) or immobilized metal affinity chromatography (IMAC). Targeted MS approaches such as parallel reaction monitoring (PRM) or multiple reaction monitoring (MRM) can specifically quantify the Ser272 phosphopeptide with high sensitivity. Combining immunoblotting with Phospho-PXN (Ser272) Antibody and MS-based phosphoproteomic analysis in parallel samples provides robust validation and can reveal unexpected phosphorylation patterns not detectable by predefined antibodies alone. This integrated approach is particularly valuable when investigating novel stimuli or inhibitors affecting paxillin phosphorylation.

What are emerging technologies for spatial and temporal analysis of paxillin phosphorylation dynamics?

Cutting-edge technologies are transforming capabilities for analyzing paxillin phosphorylation with unprecedented spatial and temporal resolution. Genetically encoded biosensors based on fluorescence resonance energy transfer (FRET) can monitor Ser272 phosphorylation in living cells in real-time, revealing rapid phosphorylation/dephosphorylation cycles during cell migration. These biosensors can be designed to specifically detect Ser272 phosphorylation by incorporating the phospho-binding domain fused to appropriate fluorophores. Super-resolution microscopy techniques including PALM, STORM, or STED provide nanoscale visualization of phosphorylated paxillin within focal adhesion complexes, uncovering substructural organization previously undetectable with conventional microscopy. For functional studies, optogenetic approaches enabling light-controlled phosphorylation or dephosphorylation of specific residues allow precise manipulation of paxillin Ser272 phosphorylation in subcellular regions. When developing these advanced approaches, researchers should validate findings using traditional biochemical methods with the Phospho-PXN (Ser272) Antibody to ensure consistency across methodologies.